The abstract is read at the publisher; the summary is JClub's.
Metabolic reprogramming in lymphocytes—shifting oxidative phosphorylation versus aerobic glycolysis, with altered fatty acid synthesis and glutamine metabolism—is linked to T-cell–mediated autoimmunity in MS, RA, and T1D.
- Why it matters: Immune dysregulation alone does not fully explain chronic inflammation in autoimmune diseases; metabolic changes in lymphocytes may help explain immune tolerance failure and pathogenicity.
- What they did: This review synthesizes immunometabolism evidence on how glucose, lipid, and mitochondrial pathways regulate T cells and B cells, and how similar changes appear in systemic lupus erythematosus (SLE).
- The result: The authors propose immunometabolism as a mechanism connecting metabolic dysregulation to tolerance failure and as a precision immunotherapy avenue, while noting the challenge of targeting specific cells without systemic toxicity.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.